HAE - Haemonetics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HAE is currently covered by 7 analysts with an average price target of $69.99. This is a potential upside of $20 (40.01%) from yesterday's end of day stock price of $49.99.

Haemonetics's activity chart (see below) currently has 180 price targets and 152 ratings on display. The stock rating distribution of HAE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 61.34% with an average time for these price targets to be met of 275.67 days.

Highest price target for HAE is $105, Lowest price target is $64, average price target is $84.43.

Most recent stock forecast was given by MICHAEL PETUSKY from BARRINGTON on 20-Oct-2025. First documented stock forecast 30-May-2013.

Currently out of the existing stock ratings of HAE, 21 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$86

$34.74 (67.77%)

$86

10 days ago
(20-Oct-2025)

19/34 (55.88%)

$34.81 (68.00%)

303

Buy

$64

$12.74 (24.85%)

$90

24 days ago
(06-Oct-2025)

11/13 (84.62%)

$14.74 (29.92%)

168

Buy

$78

$26.74 (52.17%)

$105

2 months 20 days ago
(10-Aug-2025)

6/11 (54.55%)

$25.53 (48.66%)

163

Buy

$68

$16.74 (32.66%)

$84

2 months 24 days ago
(06-Aug-2025)

3/12 (25%)

$12.37 (22.24%)

358

Buy

$100

$48.74 (95.08%)

$100

5 months 11 days ago
(19-May-2025)

5/15 (33.33%)

$31.09 (45.12%)

215

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HAE (Haemonetics) average time for price targets to be met?

On average it took 275.67 days on average for the stock forecasts to be realized with a an average price target met ratio 61.34

Which analyst has the current highest performing score on HAE (Haemonetics) with a proven track record?

MIKE MATSON

Which analyst has the most public recommendations on HAE (Haemonetics)?

Mike Matson works at NEEDHAM and has 36 price targets and 39 ratings on HAE

Which analyst is the currently most bullish on HAE (Haemonetics)?

Lawrence Keusch with highest potential upside - $103.74

Which analyst is the currently most reserved on HAE (Haemonetics)?

David Roman with lowest potential downside - -$22.26

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?